Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis VETO

Max Ratio

3.08

Dividend Yield

1.19 %

5Y Dividend Growth

77.00 %

Consecutive Years

2 years

5Y Average Payout Ratio

20.31 %

Dividend History VETO

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.19 %
Consecutive Years 2
Forward Annual Dividend 0.89 EUR
Consistent Years 5
Dividend CAGR 3Y 19.35 %
Continuous Dividends
Dividend CAGR 5Y 12.11 %
Payout Ratio TTM 17.89 %
Dividend CAGR 10Y 8.67 %
Ex Dividend Date 06/04/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth VETO

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin VETO

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income VETO

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM VETO

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio VETO

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Vetoquinol VETO

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself VETO

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 14.71
Forward PE
Enterprise Value Revenue 1.29
Price Sales TTM 1.67
Enterprise Value EBITDA 5.95
Price Book MRQ 1.51

Vetoquinol Dividends: 1.19 % Yield, History, Payment Schedule

VETO
Current price
75.00 EUR +2.6 EUR (+3.59%)
Last closed 72.40 EUR
ISIN FR0004186856
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Euronext Paris
Capitalization 887 712 190 EUR
Yield for 12 month -3.85 %
1Y
3Y
5Y
10Y
15Y
VETO
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+539 362 429 EUR

Last Year

+529 434 366 EUR

Current Quarter

+257 713 522 EUR

Last Quarter

+274 839 806 EUR

Current Year

+387 568 591 EUR

Last Year

+291 469 938 EUR

Current Quarter

+140 225 269 EUR

Last Quarter

+43 922 553 EUR
EBITDA 104 311 187 EUR
Operating Margin TTM 13.49 %
Price to Earnings 14.71
Return On Assets TTM 6.98 %
PEG Ratio
Return On Equity TTM 10.80 %
Wall Street Target Price 78.77 EUR
Revenue TTM 532 553 320 EUR
Book Value 48.23 EUR
Revenue Per Share TTM
Dividend Share 0.89 EUR
Quarterly Revenue Growth YOY -2.60 %
Dividend Yield 1.19 %
Gross Profit TTM 308 319 137 EUR
Earnings per share 5.10 EUR
Diluted Eps TTM 5.10 EUR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 6.00 %
Profit Margin 11.26 %

Technical Indicators VETO

For 52 Weeks

62.87 EUR 84.61 EUR
50 Day MA 75.19 EUR
Shares Short Prior Month
200 Day MA 75.15 EUR
Short Ratio
Shares Short
Short Percent